Breast CT: A critical perspective

Future Oncology

Volumn 2, Issue 3, 2006, Pages 325-327

  Avril, Norbert ^a   Endemann, Beate ^b   Vinnicombe, Sarah ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Diagnostic Imaging Center   (Germany)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

BREAST CANCER; BREAST SURGERY; CANCER LOCALIZATION; CANCER PATIENT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; EDITORIAL; HEALTH CARE COST; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAMMOGRAPHY; MEDICAL DOCUMENTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; THREE DIMENSIONAL IMAGING; TUMOR CALCINOSIS; X RAY;

BREAST NEOPLASMS; FEMALE; HUMANS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33745508536     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.2.3.325     Document Type: Editorial

References (7)

1. Kalender WA: CT: the unexpected evolution of an imaging modality. Eur. Radiol. 15(Suppl. 4), D21-D24 (2005).
2. Jeong YJ, Lee KS, Jeong SY et al.: Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology. 237, 675-683 (2005).
3. Schnall MD, Blume J, Bluemke DA et al.: Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 238, 42-53 (2006).
4. Smith A: Full-field breast tomosynthesis. Radiol. Manage. 27, 25-31 (2005).
5. Taillefer R: Clinical applications of 99m Tc-sestamibi scintimammography. Semin. Nucl. Med. 35, 100-115 (2005).
6. Avril N, Rose CA, Schelling M et al.: Breast imaging with positron emission tomography and fluorine- 18 fluorodeoxyglucose: use and limitations. J. Clin. Oncol. 18, 3495-3502 (2000).
7. Hawrysz DJ, Sevick-Muraca EM: Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia 2, 388-417 (2000).